Martin RF - EpiVax, Inc. - Informatics and Immunology

HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA)

by Annie De Groot | Feb 5, 2019

Time for T? Immunoinformatics addresses the challenges of vaccine design for neglected tropical and emerging infectious diseases

by epivax3 | Oct 22, 2016

Expert Review of Vaccines. Resubmitted 3 Aug 2014. Full Text

In-silico prediction of HLA-DP and -DQ epitope content is poorly correlated with clinical immunogenicity of therapeutic proteins

by epivax3 | Oct 21, 2016

Tolerization as a Rational Design Approach for Reducing the Immunogenicity of Biologics (Campath)

by epivax3 | Oct 21, 2016

iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines

by epivax3 | Jul 27, 2016

Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and...

HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA)

Time for T? Immunoinformatics addresses the challenges of vaccine design for neglected tropical and emerging infectious diseases

In-silico prediction of HLA-DP and -DQ epitope content is poorly correlated with clinical immunogenicity of therapeutic proteins

Tolerization as a Rational Design Approach for Reducing the Immunogenicity of Biologics (Campath)

iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines

Recent Posts

Categories